List of Tables
Table 1. Global Peptide Vaccine for Tumor Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Peptide Vaccine for Tumor Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Peptide Vaccine for Tumor Market Competitive Situation by Manufacturers in 2023
Table 4. Global Peptide Vaccine for Tumor Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Peptide Vaccine for Tumor Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Peptide Vaccine for Tumor Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Peptide Vaccine for Tumor Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Peptide Vaccine for Tumor Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Peptide Vaccine for Tumor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide Vaccine for Tumor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Vaccine for Tumor, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Vaccine for Tumor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Vaccine for Tumor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Vaccine for Tumor as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Vaccine for Tumor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Peptide Vaccine for Tumor Sales by Region (2019-2024) & (K Dose)
Table 18. Global Peptide Vaccine for Tumor Sales Market Share by Region (2019-2024)
Table 19. Global Peptide Vaccine for Tumor Sales by Region (2025-2030) & (K Dose)
Table 20. Global Peptide Vaccine for Tumor Sales Market Share by Region (2025-2030)
Table 21. Global Peptide Vaccine for Tumor Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Peptide Vaccine for Tumor Revenue Market Share by Region (2019-2024)
Table 23. Global Peptide Vaccine for Tumor Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Peptide Vaccine for Tumor Revenue Market Share by Region (2025-2030)
Table 25. North America Peptide Vaccine for Tumor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Peptide Vaccine for Tumor Sales by Country (2019-2024) & (K Dose)
Table 27. North America Peptide Vaccine for Tumor Sales by Country (2025-2030) & (K Dose)
Table 28. North America Peptide Vaccine for Tumor Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Peptide Vaccine for Tumor Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Peptide Vaccine for Tumor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Peptide Vaccine for Tumor Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Peptide Vaccine for Tumor Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Peptide Vaccine for Tumor Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Peptide Vaccine for Tumor Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Peptide Vaccine for Tumor Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Peptide Vaccine for Tumor Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Peptide Vaccine for Tumor Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Peptide Vaccine for Tumor Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Peptide Vaccine for Tumor Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Peptide Vaccine for Tumor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Peptide Vaccine for Tumor Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Peptide Vaccine for Tumor Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Peptide Vaccine for Tumor Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Peptide Vaccine for Tumor Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Peptide Vaccine for Tumor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Peptide Vaccine for Tumor Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Peptide Vaccine for Tumor Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Peptide Vaccine for Tumor Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Peptide Vaccine for Tumor Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Peptide Vaccine for Tumor Sales (K Dose) by Type (2019-2024)
Table 51. Global Peptide Vaccine for Tumor Sales (K Dose) by Type (2025-2030)
Table 52. Global Peptide Vaccine for Tumor Sales Market Share by Type (2019-2024)
Table 53. Global Peptide Vaccine for Tumor Sales Market Share by Type (2025-2030)
Table 54. Global Peptide Vaccine for Tumor Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Peptide Vaccine for Tumor Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Peptide Vaccine for Tumor Revenue Market Share by Type (2019-2024)
Table 57. Global Peptide Vaccine for Tumor Revenue Market Share by Type (2025-2030)
Table 58. Global Peptide Vaccine for Tumor Price (US$/Dose) by Type (2019-2024)
Table 59. Global Peptide Vaccine for Tumor Price (US$/Dose) by Type (2025-2030)
Table 60. Global Peptide Vaccine for Tumor Sales (K Dose) by Application (2019-2024)
Table 61. Global Peptide Vaccine for Tumor Sales (K Dose) by Application (2025-2030)
Table 62. Global Peptide Vaccine for Tumor Sales Market Share by Application (2019-2024)
Table 63. Global Peptide Vaccine for Tumor Sales Market Share by Application (2025-2030)
Table 64. Global Peptide Vaccine for Tumor Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Peptide Vaccine for Tumor Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Peptide Vaccine for Tumor Revenue Market Share by Application (2019-2024)
Table 67. Global Peptide Vaccine for Tumor Revenue Market Share by Application (2025-2030)
Table 68. Global Peptide Vaccine for Tumor Price (US$/Dose) by Application (2019-2024)
Table 69. Global Peptide Vaccine for Tumor Price (US$/Dose) by Application (2025-2030)
Table 70. AmbioPharm Company Information
Table 71. AmbioPharm Description and Business Overview
Table 72. AmbioPharm Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. AmbioPharm Peptide Vaccine for Tumor Product
Table 74. AmbioPharm Recent Developments/Updates
Table 75. Almac Company Information
Table 76. Almac Description and Business Overview
Table 77. Almac Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Almac Peptide Vaccine for Tumor Product
Table 79. Almac Recent Developments/Updates
Table 80. ACT Company Information
Table 81. ACT Description and Business Overview
Table 82. ACT Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. ACT Peptide Vaccine for Tumor Product
Table 84. ACT Recent Developments/Updates
Table 85. Ultimovacs Company Information
Table 86. Ultimovacs Description and Business Overview
Table 87. Ultimovacs Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Ultimovacs Peptide Vaccine for Tumor Product
Table 89. Ultimovacs Recent Developments/Updates
Table 90. Marker Therapeutics, Inc. Company Information
Table 91. Marker Therapeutics, Inc. Description and Business Overview
Table 92. Marker Therapeutics, Inc. Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Marker Therapeutics, Inc. Peptide Vaccine for Tumor Product
Table 94. Marker Therapeutics, Inc. Recent Developments/Updates
Table 95. Immatics Company Information
Table 96. Immatics Description and Business Overview
Table 97. Immatics Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Immatics Peptide Vaccine for Tumor Product
Table 99. Immatics Recent Developments/Updates
Table 100. OncoPep Company Information
Table 101. OncoPep Description and Business Overview
Table 102. OncoPep Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. OncoPep Peptide Vaccine for Tumor Product
Table 104. OncoPep Recent Developments/Updates
Table 105. Anergis Company Information
Table 106. Anergis Description and Business Overview
Table 107. Anergis Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Anergis Peptide Vaccine for Tumor Product
Table 109. Anergis Recent Developments/Updates
Table 110. Sellas Life Sciences Company Information
Table 111. Sellas Life Sciences Description and Business Overview
Table 112. Sellas Life Sciences Peptide Vaccine for Tumor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Sellas Life Sciences Peptide Vaccine for Tumor Product
Table 114. Sellas Life Sciences Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Peptide Vaccine for Tumor Distributors List
Table 118. Peptide Vaccine for Tumor Customers List
Table 119. Peptide Vaccine for Tumor Market Trends
Table 120. Peptide Vaccine for Tumor Market Drivers
Table 121. Peptide Vaccine for Tumor Market Challenges
Table 122. Peptide Vaccine for Tumor Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptide Vaccine for Tumor
Figure 2. Global Peptide Vaccine for Tumor Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Peptide Vaccine for Tumor Market Share by Type: 2023 & 2030
Figure 4. Synthetic Polypeptide Vaccines Product Picture
Figure 5. Recombinant Polypeptide Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Peptide Vaccine for Tumor Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Peptide Vaccine for Tumor Market Share by Application: 2023 & 2030
Figure 9. Infectious Disease Prevention
Figure 10. Cancer Immunotherapy
Figure 11. Others
Figure 12. Global Peptide Vaccine for Tumor Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Peptide Vaccine for Tumor Market Size (2019-2030) & (US$ Million)
Figure 14. Global Peptide Vaccine for Tumor Sales (2019-2030) & (K Dose)
Figure 15. Global Peptide Vaccine for Tumor Average Price (US$/Dose) & (2019-2030)
Figure 16. Peptide Vaccine for Tumor Report Years Considered
Figure 17. Peptide Vaccine for Tumor Sales Share by Manufacturers in 2023
Figure 18. Global Peptide Vaccine for Tumor Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Peptide Vaccine for Tumor Players: Market Share by Revenue in Peptide Vaccine for Tumor in 2023
Figure 20. Peptide Vaccine for Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Peptide Vaccine for Tumor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Peptide Vaccine for Tumor Sales Market Share by Country (2019-2030)
Figure 23. North America Peptide Vaccine for Tumor Revenue Market Share by Country (2019-2030)
Figure 24. United States Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Peptide Vaccine for Tumor Sales Market Share by Country (2019-2030)
Figure 27. Europe Peptide Vaccine for Tumor Revenue Market Share by Country (2019-2030)
Figure 28. Germany Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Peptide Vaccine for Tumor Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Peptide Vaccine for Tumor Revenue Market Share by Region (2019-2030)
Figure 35. China Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Peptide Vaccine for Tumor Sales Market Share by Country (2019-2030)
Figure 43. Mexico Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Peptide Vaccine for Tumor Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Peptide Vaccine for Tumor Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Peptide Vaccine for Tumor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Peptide Vaccine for Tumor by Type (2019-2030)
Figure 53. Global Revenue Market Share of Peptide Vaccine for Tumor by Type (2019-2030)
Figure 54. Global Peptide Vaccine for Tumor Price (US$/Dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Peptide Vaccine for Tumor by Application (2019-2030)
Figure 56. Global Revenue Market Share of Peptide Vaccine for Tumor by Application (2019-2030)
Figure 57. Global Peptide Vaccine for Tumor Price (US$/Dose) by Application (2019-2030)
Figure 58. Peptide Vaccine for Tumor Value Chain
Figure 59. Peptide Vaccine for Tumor Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
